Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection

OBJECTIVES: In some patients the immune response triggered by SARS-CoV-2 is unbalanced, presenting an acute respiratory distress syndrome which in many cases requires intensive care unit (ICU) admission. The limitation of ICU beds has been one of the major burdens in the management around the world;...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno-García, Estela, Rico, Verónica, Albiach, Laia, Agüero, Daiana, Ambrosioni, Juan, Bodro, Marta, Cardozo, Celia, Chumbita, Mariana, De la Mora, Lorena, García-Pouton, Nicole, Garcia-Vidal, Carolina, González-Cordón, Ana, Hernández-Meneses, Marta, Inciarte, Alexy, Laguno, Montse, Leal, Lorna, Linares, Laura, Macaya, Irene, Meira, Fernanda, Mensa, Josep, Moreno, Antonio, Morata, Laura, Puerta-Alcalde, Pedro, Rojas, Jhon, Solá, Montse, Torres, Berta, Torres, Manuel, Tomé, Adrià, Tuset, Montse, Castro, Pedro, Fernández, Sara, Nicolás, Josep Maria, Almuedo-Riera, Alex, Muñoz, Jose, Fernandez-Pittol, Mariana, Marcos, Maria Angeles, Soy, Dolors, Martínez, José Antonio, García, Felipe, Soriano, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2021
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179941/
https://www.ncbi.nlm.nih.gov/pubmed/33829722
http://dx.doi.org/10.37201/req/037.2021

Ejemplares similares

Ejemplares similares